Spots Global Cancer Trial Database for Muscle Dysfunction in Patients With Haematological Diseases

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Muscle Dysfunction in Patients With Haematological Diseases

Official Title: The Prevalence and the Prognostic Value of Sarcopenia Among Patients With Haematological Cancer Diseases - A Prospective Observational Cohort Study.

Study ID: NCT05150561

Conditions

Hematologic Diseases

Acute Myeloid Leukemia

Acute Lymphoid Leukemia

Myelodysplastic Syndromes

Lymphoma

Interventions

Study Description

Brief Summary: PURPOSE: To evaluate the prevalence and prognostic value of sarcopenia in patients diagnosed with hematological cancer diseases.

Detailed Description: Some patients diagnosed with malignant hematological diseases are faced with poor prognosis and thus must undergo a demanding course of treatment associated with severe deconditioning potentially leading to worse prognostic outcomes. It is currently not well-described, to what extend patients body composition at the point of diagnoses should be part of standard clinical evaluation in order to optimize therapy-efficacy. Recent findings suggest that pathophysiological alterations in skeletal muscle mass and function can have significant implications for the risk of disease progression and long-term prognosis.